Every 8-K that Harte Hanks (HHS) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow HHS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full HHS filings page.
Harte Hanks, Inc. (HHS) entered into a definitive Agreement and Plan of Merger with Star Equity Holdings, Inc., under which a Star subsidiary will merge into Harte Hanks and Harte Hanks will become a wholly owned subsidiary of Star.
Each Harte Hanks share (other than treasury and Star-held shares) will be converted into either $5.00 in cash or 0.50 share of Star’s 10% Series A Cumulative Perpetual Preferred Stock, or a mix, with total cash (including cash in lieu of fractional preferred shares) capped at $19.2 million. No fractional preferred shares will be issued; fractions will be cashed out at $10.00 per preferred share. Vested options and RSUs are cashed out or paid in preferred stock based on this merger consideration, while unvested options, unvested RSUs that do not vest at closing, and all performance stock units are cancelled without payment.
The merger requires Harte Hanks stockholder approval, effectiveness of a Star Form S‑4 registration statement, completion of up to $15 million in debt financing (or alternative financing), third‑party consents, and other customary conditions. A 30‑day go‑shop allows Harte Hanks to solicit superior proposals. Directors and certain officers signed voting and support agreements. Mutual termination fees and liability caps of $1,152,000 apply to each party in specified scenarios.
Harte Hanks, Inc. reported results of its 2026 annual meeting of stockholders. Stockholders elected four director nominees, with support levels generally around 5.0 million votes "for" and approximately 0.2 million "withheld," plus 394,667 broker non-votes for each nominee.
Stockholders also approved, on a non-binding advisory basis, the compensation of the company’s named executive officers, with 4,875,115 votes for, 246,517 against, 1,536 abstentions, and 394,667 broker non-votes. In addition, they ratified the selection of Wolf & Company P.C. as independent registered public accounting firm for the fiscal year ending December 31, 2026, with 5,506,650 votes for, 7,581 against and 3,604 abstentions.
Harte Hanks, Inc. reported first quarter 2026 results showing lower revenue and earnings while maintaining a debt-free balance sheet. Revenue was $37.3 million, down 10.3% from $41.6 million a year earlier, as legacy offerings and market headwinds weighed on sales. Operating loss widened to $0.8 million from a loss of $0.04 million, and net loss increased to $0.6 million, or $0.08 per share, compared with $0.4 million, or $0.05 per share. EBITDA declined to $0.3 million from $1.0 million, and Adjusted EBITDA fell to $0.7 million from $1.8 million, reflecting higher pressure on profitability despite restructuring. Segment revenue decreased across Customer Care, Fulfillment & Logistics, and Revenue Solutions, with notable declines in Fulfillment & Logistics. The company ended the quarter with $4.5 million in cash, no debt, and $24.3 million of available credit capacity, and management continues to emphasize a sector-aligned growth strategy targeting positive EBITDA for 2026.
Harte Hanks, Inc. reported fourth-quarter 2025 and full-year 2025 results showing lower revenue but improved bottom-line metrics. Q4 revenue was $39.9 million, down 15.4% from $47.1 million a year earlier, yet net income swung to $2.2 million, or $0.30 per share, from a $2.4 million loss.
For full year 2025, revenue declined to $159.6 million, down 13.9% from $185.2 million in 2024, and operating income fell to $0.4 million from $2.1 million. Even so, net loss narrowed sharply to $0.8 million from $30.3 million, as the prior year included $37.5 million of pension plan termination charges.
EBITDA for 2025 was $4.9 million versus $6.5 million in 2024, while Adjusted EBITDA declined to $6.9 million from $14.0 million, reflecting softer performance across segments. The company ended 2025 with $5.6 million in cash, no debt, and $24.0 million of credit line capacity, emphasizing continued focus on margin expansion and disciplined capital allocation.
Harte Hanks (HHS) furnished a press release announcing financial results for the third quarter ended September 30, 2025. The company provided the update under Item 2.02, and the release is included as Exhibit 99.1.
The information in Item 2.02, including Exhibit 99.1, is furnished and not deemed filed under the Exchange Act. Harte Hanks’ common stock trades on NASDAQ under the symbol HHS.